Top Tweets for #LDTS
The @NEJM op-ed on FDA oversight of #LDTs misses critical points. The authors do not understand molecular testing. The FDA's attempt to regulate LDTs as devices oversteps its authority, ignoring the unique role academic medical centers and pathologists play in safeguarding patient care. #VALIDAct critics, including @Pathologists @AMPath , and @ACLAlabs, highlight how current regulations under CLIA already ensure accuracy and safety, without stifling innovation. Imposing excessive FDA oversight could delay life-saving tests and restrict patient access to personalized care. #FDA #LDTs #Pathology #ClinicalLabs #PatientCare #genetics #genomics @NEJM
https://t.co/BVXmYrAS74
1/2 - A win for innovation in lab medicine!
A U.S. Federal Court has overturned the FDA’s rule on laboratory-developed tests (LDTs), removing barriers that could have slowed innovation in diagnostics.
#CIZ #CancerDiagnostics #LDTs #MedicalInnovation #FDA #EarlyDetection #Cancer
[1/2] Latest breaking news!
The U.S. District Court for the Eastern District of Texas has just vacated and set aside the FDA’s Final Rule on Laboratory Developed Tests (LDTs).
#LDTs #Diagnostics #FDA
In precision oncology, time matters.
In our latest white paper learn how you can:
🔸Accelerate turnaround times
🔸Improve patient outcomes,
🔸Maximize the promise of precision oncology
Download the white paper now: https://t.co/xrUW83ENik
#EraofVelsera #LDTs #oncology
ASCP reached out to the Trump transition team, urging them to rescind the FDA's Final Rule on #LDTs. This rule, along with the VALID Act, places costly, unnecessary burdens on clinical labs without boosting patient outcomes.
ASCP President Dr. Greg Sossaman emphasized that current CLIA regulations already ensure that LDTs are safe, effective, and flexible enough to keep up with innovation. Maintaining nimble, quality lab services is crucial to patient care! ASCP stands firm in protecting access to affordable and high-quality testing. Read more at: https://t.co/eMiO2ALGCr
ASCP and four other medical specialty societies have filed an amicus curiae brief in a lawsuit seeking to overturn the U.S. Food and Drug Administration (#FDA) Final Rule claiming authority to regulate laboratory developed tests (#LDTs). Find out more about what this could mean for labs at: https://t.co/SE4HKki5lK
Listen to the latest edition of the @Pathologists podcast featuring Dr. Joe Saad discussing the FDA's LDT final rule and the CAP's ongoing advocacy efforts to protect pathologists and ensure patients can access diagnostic tests. https://t.co/gfCnQAhYD1
#LDTs #PathTwitter #PathX
🚨 Calling all molecular lab experts! 🧬 Help AMP understand the #FDARule's impact on #LDTs and #CLIA labs. Take the survey & share widely! https://t.co/w6KvUG4PIR #MolPath #IDTwitter #Genetics #hemepath #bioinformatics #pathology #PGx #cytopathology #PathTwitter #MedTwitter
Listen to the latest episode of the @Pathologists podcast featuring A. Joe Saad, MD, CPE, FCAP, discussing the FDA's LDT final rule and the CAP's ongoing advocacy efforts to protect pathologists and ensure patients can access diagnostic tests. https://t.co/agGryjjC9g #LDTs #PathX
News & Views: "@FDA’s Final Rule on #Laboratory Developed Tests" by @xandervanwijk & Others.
#MedTwitter #LabMedX #PathTwitter #LDTs
👇
https://t.co/M9mpzvH4gJ
Visit our Laboratory-Developed Test Oversight page for the latest CAP resources, advocacy tools, and webinars on #LDTs https://t.co/VRMflfsqJ7
#PathTwitter #PathX
Looking for Michelle Campbell's session during Annual Meeting? You can find Michelle leading two educational sessions during #ASCP2024 on Thursday at 8-9 AM covering a Laboratory Developed Tests panel and Friday from 10:45-11:45 AM covering a Practical Approach to Phase 1 #LDTs Ruling. Review our schedule and add these sessions to your agenda to avoid missing out: https://t.co/SHUzrn1JD5
𝐊𝐚𝐥𝐨𝐫𝐚𝐦𝐚’𝐬 𝐅𝐫𝐞𝐞 𝐋𝐃𝐓 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞: 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐍𝐨𝐰
Preview insights from our latest report “The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028.”
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐇𝐞𝐫𝐞:
https://t.co/CrYAnJ0x1l
#LDTs #LabDevelopedTests
.@Pathologists members are asking Congress to intervene before the FDA implements its oversight regulations on #LDTs during our August Recess Rally. Learn how you can engage online: https://t.co/hnGwZlxDfO
#CAPAdvocacy #Advocate #Engage #AugustRecess
AMP has filed a lawsuit against the FDA to challenge the final rule on LDTs. AMP stands firm in its commitment to ensuring that regulations enhance patient care without stifling innovation. More Info: https://t.co/3jX85Rj6Sf
#MolPath #LDTs #FDARegulation #PatientCare #CLIAMod
This comprehensive study explores the dynamic LDT landscape, including new FDA regulations and implications, market trends and regional growth, and the impact of #AI on LDT development.
https://t.co/7vwqvB2msR
#LDTs #LaboratoryDevelopedTests #mrx #FDA #IVD #InVitroDiagnostics
Last Seen Hashtags on Sotwe
missionary
Seen from United Kingdom
omegle #nolimit()***
Seen from Pakistan
刺腹
女高s
Seen from Japan
ballsshaving
Seen from United States
ミスターロビンの口説き方
Seen from Japan
cindo
Seen from Indonesia
nolimit ()***********************************
Seen from Singapore
baitrequest
Seen from United States
TEENAGER filter:videos
Seen from Austria
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.2M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
88.7M followers
Taylor Swift
@taylorswift13
82.6M followers
Lady Gaga
@ladygaga
74.1M followers
Virat Kohli
@imvkohli
71.6M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.5M followers
Neymar Jr
@neymarjr
64.5M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.8M followers
X
@x
60.8M followers